This is simply the biggest acquisition ever carried out by Dassault Systems. The French group puts $ 5.8 billion (5,11 billion euros) to provide the u.s. Medidata, the world leader in software dedicated to the support of clinical trials. Thirteen of the fifteen top-selling drugs by 2018 are based on the technology of Medidata. Last year, the group achieved a turnover of 636 million, a growth of 16 %. "The software market in the field of health weighs in at $ 60 billion. It is as much as the industrial sectors in which we are already present", welcomes Bernard Charlès, CEO of Dassault systèmes, which has achieved turnover of € 3.5 billion in 2018.

The operation of a redemption entirely in cash, funded by cash and debt. It should be buckled in the last quarter of 2019, subject to the green light of the supervisory authorities, etc.